インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2025-02-14 | SWANSON, JAMES D. | EVP, CIO | 普通株式 | 購入 | 1,961 | $0.00 |
| 2025-02-14 | SWANSON, JAMES D. | EVP, CIO | 普通株式 | 売却 | 152 | $155.26 |
| 2025-02-14 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 売却 | 15,465 | $0.00 |
| 2025-02-14 | BROADHURST, VANESSA | EVP, Global Corp Affairs | 譲渡制限付株式ユニット | 売却 | 1,830 | $0.00 |
| 2025-02-14 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 譲渡制限付株式ユニット | 売却 | 4,053 | $0.00 |
| 2025-02-14 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 売却 | 7,911 | $156.71 |
| 2025-02-14 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 購入 | 15,465 | $0.00 |
| 2025-02-14 | BROADHURST, VANESSA | EVP, Global Corp Affairs | 普通株式 | 売却 | 574 | $156.71 |
| 2025-02-14 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 売却 | 5,837 | $0.00 |
| 2025-02-14 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 売却 | 507 | $155.26 |
| 2025-02-14 | DECKER, ROBERT J | VP Corporate Controller | 普通株式 | 売却 | 104 | $155.26 |
| 2025-02-14 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | 普通株式 | 売却 | 19,282 | $0.00 |
| 2025-02-14 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 購入 | 4,014 | $0.00 |
| 2025-02-14 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | 譲渡制限付株式ユニット | 売却 | 5,053 | $0.00 |
| 2025-02-14 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | 普通株式 | 売却 | 8,386 | $156.71 |
| 2025-02-14 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | 普通株式 | 購入 | 19,282 | $0.00 |
| 2025-02-14 | DECKER, ROBERT J | VP Corporate Controller | 普通株式 | 購入 | 850 | $0.00 |
| 2025-02-14 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 売却 | 1,144 | $156.71 |